Hepatoprotective effects of a novel polysaccharide from Aronia melanocarpa against alcohol‐induced liver injury via gut microbiota modulation
Journal of the Science of Food and Agriculture · 2026
DOI: 10.1002/jsfa.70875 ↗At a glance
Journal article in Journal of the Science of Food and Agriculture, 2026. Written by Yaqing Liu and 7 co-authors. Institution: Engineering Research Center of Edible and Medicinal Fungi, Ministry of Education, Jilin Agricultural University, Changchun, China. Major MEDLINE topics: Photinia, Polysaccharides, Gastrointestinal Microbiome, Liver Diseases, Alcoholic. 104 references. Funded by: JJKH20220324KJ, Science and technology research project of Education Department of Jilin Province.
Abstract (original language)
BACKGROUND Alcoholic liver disease (ALD) remains a major global health burden and a leading cause of liver‐related morbidity. Naturally derived polysaccharides have attracted increasing attention for their potential in ALD management. RESULTS In this study, a novel polysaccharide (AMP) was isolated and purified from Aronia melanocarpa . Structural characterization showed that AMP had a molecular weight of 27.5 kDa, exhibited excellent thermal stability, and was primarily composed of glucose, mannose, rhamnose, glucuronic acid, and xylose. To evaluate the hepatoprotective effects of AMP, an ALD mouse model was established through chronic ethanol administration. AMP demonstrated hepatoprotective potential against alcohol‐induced liver injury by ameliorating hepatic damage, suppressing pro‐inflammatory cytokines (interleukin‐6 (IL‐6), tumor necrosis factor‐α (TNF‐α) and interleukin‐1β (IL‐1β)), enhancing activities of antioxidant enzymes (superoxide dismutase (SOD) and glutathione peroxidase (GSH‐Px)) and glutathione (GSH) content, and decreasing levels of oxidative byproducts (nitric oxide (NO) and malondialdehyde (MDA)). 16S rRNA and ITS sequencing revealed that AMP effectively reversed alcohol‐induced gut dysbiosis. Notably, AMP not only increased beneficial bacterial families such as Bacteroidaceae and Lachnospiraceae, while decreasing the proportions of Erysipelotrichaceae and Ruminococcaceae, but also remodeled the gut mycobiome by enriching the protective fungus Kazachstania and depleting pro‐inflammatory fungi including Mortierella and Candida . Notably, these protective effects may be mediated through regulation of ‘bacteria–fungi’ interactions. CONCLUSION AMP is a promising therapeutic agent that combines direct hepatoprotection for gut microbiota restoration. © 2026 Society of Chemical Industry.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Engineering Research Center of Edible and Medicinal Fungi, Ministry of Education, Jilin Agricultural University, Changchun, China.
- College of Plant Protection and Fungi, Jilin Agricultural University, Changchun, China.
- College of Life Science, Jilin Agricultural University, Changchun, China.
ORCID profiles: Ling Su
Funding
- JJKH20220324KJ
- Science and technology research project of Education Department of Jilin Province
Cite
APA
Liu, Y., Wang, T., Zhang, Y., Jia, Z., An, C., Yang, Y., Su, L., & Li, Y. (2026). Hepatoprotective effects of a novel polysaccharide from Aronia melanocarpa against alcohol‐induced liver injury via gut microbiota modulation. Journal of the Science of Food and Agriculture. https://doi.org/10.1002/jsfa.70875
Vancouver
Liu Y, Wang T, Zhang Y, Jia Z, An C, Yang Y, et al. Hepatoprotective effects of a novel polysaccharide from Aronia melanocarpa against alcohol‐induced liver injury via gut microbiota modulation. Journal of the Science of Food and Agriculture. 2026. doi:10.1002/jsfa.70875
BibTeX
@article{Liu2026,
author = {Liu, Yaqing and Wang, Tianci and Zhang, Yumei and Jia, Zikun and An, Canghai and Yang, Yuhang and Su, Ling and Li, Yuting},
title = {Hepatoprotective effects of a novel polysaccharide from Aronia melanocarpa against alcohol‐induced liver injury via gut microbiota modulation},
journal = {Journal of the Science of Food and Agriculture},
year = {2026},
doi = {10.1002/jsfa.70875}
}
EUVIMED